VO2 Max and the Watt Test: Lab 'Normal' vs Functional Optimal

What the Watt test and VO2 max actually measure

VO2 max is the maximum rate at which the body can consume oxygen during exhaustive exercise. It reflects the combined capacity of the lungs to move air and extract oxygen, the heart to deliver oxygenated blood, and skeletal muscle to use that oxygen to produce energy. VO2 max is a physiological ceiling, not a measure of technique or motivation.

The Watt test, also called a maximal incremental cycle ergometer test or ramp protocol, estimates VO2 max from peak power output. The rider pedals against progressively increasing resistance until volitional exhaustion, typically over 8 to 12 minutes. Estimation formulas commonly used in this setting derive VO2 max (mL/kg/min) from peak watts divided by body weight, plus a resting correction term. Cycle-ergometer protocol descriptions exist in the sports-science literature, though the exact formula, sample population, and error margin behind any specific equation should be confirmed against the original methods section before it is presented to patients as precise.

Direct VO2 max testing uses a metabolic cart with breath-by-breath gas analysis and is the reference standard. It requires specialized equipment and trained staff, which is why cycle-based Watt tests, step tests, and submaximal nomograms are used more often in general clinical and fitness settings. These estimation methods typically fall within roughly 5 to 10 percent of a directly measured value in healthy adults, which is adequate for screening and trend-tracking but not a substitute for direct measurement when clinical precision matters, such as heart-failure functional staging.

Should you take a maximal or submaximal test?

Maximal tests (Watt test, treadmill ramp) require pushing to volitional exhaustion and are contraindicated without medical clearance in people with recent myocardial infarction, unstable angina, uncontrolled arrhythmia, severe aortic stenosis, or acute illness. Submaximal step tests and nomogram-based estimates avoid this risk but trade away some accuracy. Anyone with cardiovascular symptoms during exertion, chest pain, unexplained syncope, or severe breathlessness disproportionate to effort should seek in-person evaluation before undergoing any maximal exercise test, and should treat symptoms occurring during a test as a reason to stop immediately.

Lab "normal" ranges: what they mean and why they undersell the target

Standard reference ranges for VO2 max are built from population averages, and population averages in the United States skew toward inactive adults. The American Heart Association's 2016 scientific statement proposing cardiorespiratory fitness as a clinical vital sign discusses age- and sex-stratified norms drawn from large testing cohorts. The full statement is available through the American Heart Association.

"Normal" in this context means statistically typical for a largely sedentary reference population. It does not mean optimal for cardiovascular health or longevity, and the distinction matters clinically: a result labeled "fair" or even "average" on a standard chart can still sit below the fitness levels associated with materially lower mortality in prospective cohorts.

Population averages versus mortality risk

A widely cited analysis of over 100,000 patients who underwent treadmill exercise testing at a single health system found that all-cause mortality declined continuously across the fitness spectrum, without an obvious plateau at the high end, and that the highest-fitness group had substantially lower mortality than the lowest-fitness group after adjustment for age, sex, and comorbidities. The exact hazard ratios and percentile cut points reported in that paper should be checked directly before being quoted as precise numbers in patient-facing material, since secondary summaries of this study vary in how they round the reported effect sizes.

Separately, a 2002 cohort study following men referred for exercise testing found that each incremental increase in exercise capacity, measured in METs, was associated with improved survival, and that men who could sustain a workload of roughly 10 METs (about 35 mL/kg/min) had meaningfully better outcomes than those who could not. The study appears in the New England Journal of Medicine. A separate meta-analysis of cardiorespiratory fitness and mortality in men and women reported a similar per-MET mortality benefit across pooled cohorts. That meta-analysis is indexed on PubMed. The two papers studied different populations (one all-male referred-for-testing cohort, one pooled mixed-sex meta-analysis), so their point estimates should not be treated as interchangeable; they are cited here because they point in the same direction, not because they report an identical number.

How reference categories are built, and why they decline with age

Fitness classification charts typically stratify VO2 max into tiers such as very poor, poor, fair, good, excellent, and superior, with thresholds shifting by decade because aerobic capacity declines with age. That decline is not fixed: cross-sectional and longitudinal data generally describe a steeper decline in sedentary adults than in adults who remain consistently active, though the exact percentage-per-decade figures vary by dataset and should be treated as approximate rather than precise. Background on age-related decline in cardiorespiratory fitness has been discussed in exercise-physiology reviews.

A 45-year-old man with a VO2 max of 30 mL/kg/min might be labeled "fair" on a standard chart. That label describes his rank among his peers, most of whom are also sedentary. It does not by itself tell him whether he is above or below the fitness level linked to lower mortality risk in the cohort literature above.

The strongest available evidence indicates that cardiorespiratory fitness, measured as VO2 max, behaves as a continuous mortality predictor rather than a pass/fail lab value: risk falls progressively as fitness rises, with no clear plateau even at high levels, in large treadmill-testing cohorts (Mandsager et al., JAMA Network Open, 2018). Lab reference ranges describe what is typical for a mostly sedentary population, not what is protective. A result inside the "normal" range on a standard chart can still fall below the fitness band associated with substantially lower cardiovascular and all-cause mortality in the cohort data, which is why age- and sex-adjusted percentile standing is a more useful clinical anchor than a single "normal/abnormal" cutoff.

Which VO2 max test fits which situation

Anchor a real baseline with a standardized Watt test or direct measurement first. Wearable estimates are reasonable for watching the trend line move after that, not for deciding whether you have a clinically low VO2 max in the first place.

The functional optimal: where the evidence points, and where it doesn't

"Optimal" here means the fitness band that large cohort studies associate with the lowest observed mortality risk, not simply a performance goal. Several independent literatures converge on the idea that risk keeps falling as fitness rises into the "good" and "excellent" categories, without the modest gains near the sedentary end being the whole story.

The roughly 10-MET marker

Ten METs corresponds to roughly 35 mL/kg/min. Reaching this workload during a graded exercise test has been associated with better survival in referred-for-testing cohorts such as the NEJM study cited above. This threshold is not elite; sustaining a brisk jog or moderate-resistance cycling for the duration of a test can reach it, and many adults can move toward it within several months of structured training. It should be read as a marker drawn from a specific study population, not a universal cutoff that guarantees a given individual's risk category.

Age-adjusted targets: use as a directional guide, verify before quoting precisely

Cooper Institute and ACSM-style normative tables place the "excellent" or "superior" categories at roughly the following levels, drawn from published age-stratified norms. Treat the exact cut points as approximate; different reference populations and test protocols produce somewhat different numbers, and the table below should be checked against a current ACSM or Cooper Institute reference table before being used for individualized counseling.

VO2 max as a metabolic health signal, not a standalone number

Higher aerobic capacity correlates with better insulin sensitivity and a more favorable lipid profile in observational data. Some observational studies have reported an association between cardiorespiratory fitness and reduced incident type 2 diabetes risk; the exact magnitude of any such effect should be verified before being restated as a precise percentage, since the population and adjustment model matter to the size of the effect.

For readers using GLP-1 therapy or testosterone replacement, it is reasonable to expect that improved cardiorespiratory fitness and pharmacologic metabolic treatment work through complementary, not competing, mechanisms. This is a plausible extrapolation from separate literatures on exercise and on these therapies, not a claim supported by a trial that tested the combination directly, and it should be presented to patients that way.

What a high VO2 max means clinically

A VO2 max above the "excellent" band for age and sex is a favorable signal. It suggests the heart adapts well under load, the vasculature responds appropriately to exercise demand, and skeletal muscle oxidative capacity is reasonably intact.

Higher cardiorespiratory fitness has been associated with lower resting blood pressure and lower incident hypertension risk in longitudinal cohort data, including analyses from long-running community cohort studies. Higher fitness in later life has also been associated with larger hippocampal volume and improved spatial memory in a randomized aerobic-exercise trial in older adults. That trial is indexed on PubMed. These are real, peer-reviewed findings, but association and even a single RCT do not establish that raising VO2 max will produce a specific cognitive or cardiovascular outcome in every individual; they establish a direction and a plausible mechanism.

Reported associations between higher fitness and endogenous testosterone or improved thyroid hormone sensitivity are directionally consistent across smaller studies but are not as strongly established as the mortality and blood-pressure associations above, and the causal direction is likely bidirectional (fitter people may also have more favorable baseline hormone status for unrelated reasons).

What a low VO2 max means clinically

A VO2 max below roughly the 25th percentile for age and sex is a signal that warrants the same clinical attention as an abnormal LDL or fasting glucose result. Large cohort data link the lowest fitness category to substantially higher all-cause mortality risk relative to higher-fitness groups over multi-year follow-up. A large treadmill-testing cohort study has reported this association; the specific hazard ratio should be confirmed against the original paper before it is quoted as an exact figure.

Low cardiorespiratory fitness is also relevant in heart failure care. VO2 max thresholds are commonly discussed in heart-failure and transplant-evaluation literature as part of functional staging, though the exact numeric cutoff used varies by guideline version and should be confirmed against a current heart-failure society guideline rather than taken from a general-audience article.

If a VO2 max result seems lower than expected for reported activity level

Consider evaluation for:

• Anemia, which reduces oxygen-carrying capacity
• Hypothyroidism, including subclinical cases with a normal free T4 but an elevated TSH, since thyroid hormone affects mitochondrial efficiency
• Low testosterone, which can reduce skeletal muscle oxidative capacity and red cell mass
• Subclinical coronary artery disease limiting cardiac output under load
• Autonomic dysfunction following illness, including reported patterns after COVID-19 infection

A single VO2 max number does not diagnose any of these; it is a prompt for a targeted workup, not a replacement for one. New or worsening exertional chest pain, syncope, or disproportionate breathlessness during testing or daily activity warrants urgent medical evaluation rather than a wait-and-retest approach.

How to raise VO2 max: what the training evidence supports

VO2 max responds to training through increased stroke volume, greater mitochondrial density, improved capillary density in working muscle, and more efficient oxygen extraction.

High-intensity interval training

A frequently studied protocol is four 4-minute intervals at roughly 90 to 95 percent of maximum heart rate, separated by active recovery, performed several times per week. A controlled comparison of training protocols over 8 weeks found that this style of interval training produced the largest VO2 max gains among the protocols tested, with meaningfully smaller gains from continuous long, slow-distance training. The study is indexed on PubMed. The exact mL/kg/min improvement reported in that study should be checked directly before being cited as a specific number, since different summaries of it have rounded differently.

A separate systematic review and meta-analysis of high-intensity interval training studies reported a pooled improvement in VO2 max over roughly 8 to 12 weeks, with larger relative gains typically seen in participants who started less fit.

Zone 2 training as a base

Sustained aerobic exercise at roughly 60 to 70 percent of maximum heart rate, often called Zone 2, supports mitochondrial density and fat oxidation with a lower recovery cost than high-intensity work. Research on training intensity distribution in endurance athletes describes a common pattern of a large majority of training volume at low intensity and a smaller proportion at high intensity, an approach often called polarized training. A practical, moderate approach for most adults combines several Zone 2 sessions per week with one or two higher-intensity sessions, though the ideal ratio for a given person's goals and joint tolerance is a matter of programming judgment rather than a fixed evidence-based rule.

Resistance training's role

Resistance training does not raise VO2 max directly, but it can improve movement efficiency and lean mass, which lowers the oxygen cost of a given submaximal workload. A meta-analysis of concurrent aerobic-and-resistance training in adults with cardiovascular disease reported greater VO2 max improvement with combined training than aerobic training alone. This finding comes from a cardiovascular-disease population specifically, and applying it to healthy adults without cardiovascular disease is a reasonable extrapolation, not a direct finding.

Realistic timeline

Sedentary adults commonly see measurable VO2 max improvement within 8 to 12 weeks of structured training, with larger relative gains typical in those starting from a lower baseline. Going from a low baseline to a materially higher one over roughly six months is a realistic goal for many people with consistent training and appropriate programming, though individual response varies and some adults are genuine "non-responders" or "low responders" to a given training stimulus in exercise-physiology literature.

How hormonal status can affect VO2 max

Testosterone, thyroid hormone, and related hormonal axes influence cardiac and skeletal muscle function in ways that plausibly affect VO2 max, though the strength of direct evidence varies by hormone.

Testosterone supports red blood cell production, which affects the oxygen-carrying capacity of blood; this is one proposed mechanism behind the average difference in VO2 max between men and women at similar training status. A randomized trial of testosterone treatment in older men with low testosterone (part of the Testosterone Trials program) reported improvements in physical function measures over 12 months compared with placebo. The exact citation available for this claim in current sourcing describes a related substudy on bone density and strength rather than the specific walking-distance or physical-function outcome, so that particular numeric claim needs independent verification against the correct Testosterone Trials physical-function paper before it is used in patient-facing material. a related bone-density substudy from the Testosterone Trials program exists, for reference, with the caveat above.

Thyroid hormone affects mitochondrial biogenesis and oxidative phosphorylation efficiency, and subclinical hypothyroidism has been associated with reduced exercise capacity in some studies. A full thyroid panel including free T3, not TSH alone, is reasonable when VO2 max is unexpectedly low, since T3 is the more direct mitochondrial signal. Research on free T3 and cardiorespiratory fitness is indexed on PubMed.

None of this supports using a VO2 max result to diagnose a hormonal condition on its own, or using hormone therapy as a first-line treatment for a low VO2 max in someone with normal labs. Testosterone therapy and thyroid hormone treatment carry their own indications, contraindications, and monitoring requirements that are independent of exercise capacity and should be decided on their own clinical merits.

Testing frequency and monitoring

Repeating a VO2 max estimate roughly every 8 to 12 weeks during an active training block is often enough to detect real adaptation above test-retest noise. Annual testing is reasonable during a maintenance phase. A drop of several mL/kg/min between tests without an obvious explanation, such as illness, injury, or a period of reduced training, is worth discussing with a clinician, including consideration of an ECG stress evaluation, complete blood count, and metabolic panel depending on the clinical picture.

Consumer wearables now estimate VO2 max from heart rate and movement data, with validation studies commonly reporting mean errors in the mid-single-digit percentage range against direct measurement. A validation study of wearable VO2 max estimates is indexed on PubMed. This level of accuracy is useful for watching a trend move in the right direction; it is not precise enough to serve as a clinical baseline on its own.

Evidence boundary: what is established, what is plausible, what is not

Established, with support from large cohort studies and at least one major cardiology society statement: cardiorespiratory fitness behaves as a continuous, strong predictor of all-cause mortality, low fitness is a meaningful clinical risk marker independent of some traditional risk factors, and structured aerobic training, particularly higher-intensity interval work, reliably raises VO2 max over 8 to 12 weeks in most adults.

Plausible but not established by a direct trial cited here: that raising VO2 max through training causally lowers an individual's mortality risk by the same magnitude seen in observational cohorts (the cohort data show association, not a randomized mortality outcome trial); that testosterone or thyroid optimization specifically improves VO2 max in individuals with normal baseline hormone levels; that combining GLP-1 therapy with aerobic training produces effects beyond what either produces alone.

Not established, or not verifiable from the sources available for this article: precise percentage decline in VO2 max per decade of aging; the exact hazard ratio for low versus high fitness reported in specific cohort studies (confirm against the primary paper before quoting a number); the specific physical-function finding attributed here to a testosterone trial, since the citation on hand supports a related but distinct bone-density substudy; any single VO2 max number as an individualized diagnostic or dosing threshold. Readers and clinicians should treat specific percentages and hazard ratios in this space as directionally reliable but confirm the exact figure against the primary paper before using it in a clinical or counseling context.